The two mainstays of nonpharmacological spasticity management are the removal of noxious stimuli that can drive hypertonicity and the application of physical modalities. Comorbidities of neurological ...
Three medications have spasticity reduction as their primary indication: baclofen (Lioresal ®), dantrolene (Dantrium ®), and tizanidine (Zanaflex ®). These drugs represent the mainstays of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results